tiprankstipranks
Lepu Biopharma Co. Ltd. Class H (HK:2157)
:2157
Hong Kong Market
2157
Lepu Biopharma Co. Ltd. Class H
RESEARCH TOOLSreports
Want to see HK:2157 full AI Analyst Report?

Lepu Biopharma Co. Ltd. Class H (2157) Stock News & Sentiment

4 Followers
Lepu Biopharma Shareholders Approve All Resolutions at 2025 AGM
Premium
Company Announcements
Lepu Biopharma Shareholders Approve All Resolutions at 2025 AGM
2d ago
2157
Lepu Biopharma Exits Biotech Marker Regime After Meeting HKEX Mainboard Tests
Premium
Company Announcements
Lepu Biopharma Exits Biotech Marker Regime After Meeting HKEX Mainboard Tests
15d ago
2157
Lepu Biopharma Sets 2025 AGM to Vote on Governance, Profit Plan and Share Mandate
Premium
Company Announcements
Lepu Biopharma Sets 2025 AGM to Vote on Governance, Profit Plan and Share Mandate
24d ago
2157
Lepu Biopharma Plans New Supervisor Appointment and Registered Address Change
Premium
Company Announcements
Lepu Biopharma Plans New Supervisor Appointment and Registered Address Change
24d ago
2157
Lepu Biopharma Swings to Profit as ADC Pipeline and Licensing Deals Gain Traction
Premium
Company Announcements
Lepu Biopharma Swings to Profit as ADC Pipeline and Licensing Deals Gain Traction
2M ago
2157
Lepu Biopharma Sets March 25 Board Meeting to Approve 2025 Annual Results
Premium
Company Announcements
Lepu Biopharma Sets March 25 Board Meeting to Approve 2025 Annual Results
2M ago
2157
Lepu Biopharma Signals 2025 Profit on Strong Oncology Sales and Licensing Gains
Premium
Company Announcements
Lepu Biopharma Signals 2025 Profit on Strong Oncology Sales and Licensing Gains
2M ago
2157
More HK:2157 News >

2157 News on the Web

Huachuang Securities Keeps Their Buy Rating on Lepu Biopharma Co. Ltd. Class H (2157)
TipRanks News
Neutral
Lepu Biopharma Swings to Profit as ADC Pipeline and Licensing Deals Gain Traction
TipRanks News
Bullish
Lepu Biopharma Sets March 25 Board Meeting to Approve 2025 Annual Results
TipRanks News
Neutral
Lepu Biopharma Signals 2025 Profit on Strong Oncology Sales and Licensing Gains
TipRanks News
Bullish
Lepu Biopharma Gains US$45 Million Milestone as AstraZeneca Advances Claudin 18.2 ADC to Phase III
TipRanks News
Neutral
Lepu Biopharma Secures Upfront Payment and Sets Royalty Terms in Excalipoint Licensing Deal
TipRanks News
Neutral
Lepu Biopharma Shareholders Approve RSU Scheme and Share Mandate at 2025 EGM
TipRanks News
Neutral
Lepu Biopharma Updates Articles of Association Following H Shares Issuance
TipRanks News
Neutral

News Score - Last 7 Days

Very Positive
HK:2157
Sector Average
Media Buzz
This Week1 articles
Weekly Average0.75 articles
News Sentiment
This Week100%
Sector Average76%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is HK:2157’s Media Buzz Sentiment?
1 articles about HK:2157 were published this week. In an average week, 0.75 articles are published.
    What is HK:2157’s weekly average amount of articles?
    In an average week, 0.75 articles about HK:2157 are published.
      What is HK:2157’s News Sentiment?
      100% of articles about HK:2157 were positive this week, compared to its sector average of 76%.
        Healthcare Stocks that are Trending in the News
        GOSSGossamer Bio
        RLAYRelay Therapeutics
        CGENCompugen
        PROKProKidney
        ROIVRoivant Sciences
        Showing the stocks with the most bullish news sentiment over the past week